Sloning to Synthesize Genes Using Automated Technology

Jul 19, 2006

NEW YORK (GenomeWeb News) - Sloning Biotechnology has entered the synthetic gene-production market this month with an automated process, the company said today.

The company's technology, named Slonomics, will use a library of universal double-stranded DNA building blocks that the company will assemble with industrial robotic machines.

Additional details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Main menu